|
77
|
271
|
4yhtA |
Braf complexed with an inhibitor |
|
112
|
327
|
5cs6A |
Crystal structure of ck2alpha with compound 3 bound |
|
163
|
501
|
4yhjA |
Structure and function of the hypertension variant a486v of g protein-coupled receptor kinase 4 (grk4) |
|
107
|
331
|
5cqwA |
Tetragonal complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
89
|
278
|
5cy3A |
Syk catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor |
|
113
|
326
|
5cvgA |
Crystal structure of ck2alpha with a novel closed conformation of the ad loop |
|
112
|
327
|
5cu6A |
Crystal structure of ck2alpha |
|
80
|
289
|
5ajqA |
Human lok (stk10) in complex with bosutinib |
|
110
|
324
|
5cshA |
Crystal structure of ck2alpha with compound 4 bound |
|
113
|
328
|
5cu2A |
Crystal structure of ck2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoat bound |
|
59
|
277
|
5d12A |
Kinase domain of csrc in complex with rl40 |
|
110
|
327
|
5csvA |
Crystal structure of ck2alpha with compound 6 bound |
|
101
|
358
|
5airA |
Structural analysis of mouse gsk3beta fused with lrp6 peptide. |
|
120
|
347
|
4yljA |
Crystal structure of dyrk1a in complex with 10-iodo-substituted 11h-indolo[3,2-c]quinoline-6-carboxylic acid inhibitor 5j |
|
116
|
348
|
5aikA |
Human dyrk1a in complex with ldn-211898 |
|
84
|
297
|
5cwzA |
Crystal structure of the kinase domain of human traf2 and nck-interacting protein kinase |
|
92
|
294
|
4ypdA |
Crystal structure of dapk1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine |
|
116
|
325
|
5cu3A |
Crystal structure of ck2alpha with compound 10 bound |
|
64
|
276
|
5d10A |
Kinase domain of csrc in complex with rl236 |
|
112
|
327
|
5cu4A |
Crystal structure of ck2alpha with compound 10 bound |
|
84
|
274
|
4yznA |
Humanized roco4 bound to compound 19 |
|
99
|
323
|
5cziA |
Egfr l858r mutant in complex with a shc peptide substrate |
|
101
|
328
|
5cquA |
Monoclinic complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
101
|
289
|
4ythA |
Discovery of vx-509 (decernotinib): a potent and selective janus kinase (jak) 3 inhibitor for the treatment of autoimmune diseases |
|
107
|
402
|
4yzdA |
Crystal structure of human phosphorylated ire1alpha in complex with adp-mg |
|
94
|
277
|
5cxhA |
Syk catalytic domain complexed with a potent orally bioavailable thiazole inhibitor |
|
60
|
276
|
4yzmA |
Humanized roco4 bound to lrrk2-in1 |
|
111
|
327
|
5cvfA |
Crystal structure of ck2alpha with compound 5 bound |
|
77
|
298
|
5d1jA |
Crystal structure of cyclin-dependent kinase 2 (cdk2-wt) complex with n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl] methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (bms-387032) |
|
111
|
326
|
5ct0A |
Crystal structure of ck2alpha with 3-(3-chloro-4-(phenyl)benzylamino)propan-1-ol bound |
|
102
|
297
|
4yo6A |
Irak4-inhibitor co-structure |
|
156
|
475
|
4ysmA |
Calcium-dependent protein kinase from eimeria tenella |
|
78
|
273
|
5ct7A |
Braf in complex with raf265 |
|
92
|
323
|
5czhA |
Egfr l858r mutant in complex with an optimal peptide substrate |
|
119
|
348
|
4yllA |
Crystal structure of dyrk1aa in complex with 10-bromo-substituted 11h-indolo[3,2-c]quinolone-6-carboxylic acid inhibitor 5t |
|
123
|
461
|
4ygaA |
Cdpk1, from toxoplasma gondii, bound to inhibitory vhh-1b7 |
|
86
|
294
|
4ypsA |
(r)-2-phenylpyrrolidine substitute imidazopyridazines: a new class of potent and selective pan-trk inhibitors |
|
112
|
327
|
5cvhA |
Crystal structure of ck2alpha |
|
78
|
273
|
5csxA |
Crystal structure of b-raf in complex with bi 882370 |
|
159
|
465
|
4yjnA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1639 |
|
80
|
276
|
5d11A |
Kinase domain of csrc in complex with rl235 |
|
81
|
297
|
4yneA |
(r)-2-phenylpyrrolidine substitute imidazopyridazines: a new class of potent and selective pan-trk inhibitors |
|
78
|
268
|
4yhfA |
Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor |
|
75
|
273
|
5cswA |
B-raf in complex with dabrafenib |
|
85
|
299
|
5cyiA |
Cdk2/cyclin a covalent complex with 6-(cyclohexylmethoxy)-n-(4-(vinylsulfonyl)phenyl)-9h-purin-2-amine (nu6300) |
|
94
|
316
|
5cnoA |
Crystal structure of the egfr kinase domain mutant v924r |
|
113
|
328
|
5cx9A |
Crystal structure of ck2alpha with (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoate bound |
|
105
|
350
|
4ynoA |
Crystal structure of mapk13 at inactive form |
|
111
|
324
|
5ctpA |
Crystal structure of ck2alpha with n-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide bound |
|
105
|
402
|
4yzcA |
Crystal structure of pire1alpha in complex with staurosporine |
